18 min

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications Gut Podcast

    • Medicine

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Herbert Tilg who is the Head of Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Innsbruck, Austria on on the Recent Advances in Clinical Practice paper "MASLD: a systemic metabolic disorder with cardiovascular and malignant complications" published in paper copy in Gut in April 2024.
Read the paper: https://gut.bmj.com/content/73/4/691 Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). 

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Herbert Tilg who is the Head of Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Innsbruck, Austria on on the Recent Advances in Clinical Practice paper "MASLD: a systemic metabolic disorder with cardiovascular and malignant complications" published in paper copy in Gut in April 2024.
Read the paper: https://gut.bmj.com/content/73/4/691 Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). 

18 min